Detail
Článek
Web zdroj
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Post-therapeutic cure criterion in chronic Chagas disease using Trypanosoma cruzi chimeric proteins

TBS. Pavan, LM. Leony, WV. de Souza, EF. Santos, R. Tavares Daltro, N. Erdens Maron Freitas, LC. Medrado Vasconcelos, F. Lopes Habib, AAO. Silva, P. Alejandra Fiorani Celedon, D. Dias Sampaio, NI. Tonin Zanchin, SA. Longhi, FL. Neves Santos

. 2024 ; 71 (-) : . [pub] 20240320

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25000317

Chagas disease (CD) is a neglected disease caused by Trypanosoma cruzi Chagas, 1909. Causative treatment can be achieved with two drugs: benznidazole or Nifurtimox. There are some gaps that hinder progress in eradicating the disease. There is no test that can efficiently assess cure control after treatment. Currently, the decline in anti-T. cruzi antibody titres is assessed with conventional serological tests, which can take years. However, the search for new markers of cure must continue to fill this gap. The present study aimed to evaluate the decline in serological titres using chimeric proteins after treatment with benznidazole in chronic patients diagnosed with CD. It was a prospective cross-sectional cohort study between 2000 and 2004 of T. cruzi-positive participants from the Añatuya region (Argentina) treated with benznidazole. Serum samples from ten patients were collected before treatment (day zero) and after the end of treatment (2, 3, 6, 12, 24 and 36 months). For the detection of anti-T. cruzi antibodies, an indirect ELISA was performed using two chimeric recombinant proteins (IBMP-8.1 and IBMP-8.4) as antigens. The changes in reactivity index within the groups before and after treatment were evaluated using the Friedman test. All participants experienced a decrease in serological titres after treatment with benznidazole, especially IBMP-8.1. However, due to the small number of samples and the short follow-up period, it is premature to conclude that this molecule serves as a criterion for sustained cure. Further studies are needed to validate tests based on these or other biomarkers to demonstrate parasitological cure.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25000317
003      
CZ-PrNML
005      
20250110092635.0
007      
ta
008      
250107e20240320xr f 000 0|eng||
009      
AR
024    7_
$a 10.14411/fp.2024.004 $2 doi
035    __
$a (PubMed)38526232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Pavan, Tycha Bianca Sabaini $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000152762099
245    10
$a Post-therapeutic cure criterion in chronic Chagas disease using Trypanosoma cruzi chimeric proteins / $c TBS. Pavan, LM. Leony, WV. de Souza, EF. Santos, R. Tavares Daltro, N. Erdens Maron Freitas, LC. Medrado Vasconcelos, F. Lopes Habib, AAO. Silva, P. Alejandra Fiorani Celedon, D. Dias Sampaio, NI. Tonin Zanchin, SA. Longhi, FL. Neves Santos
520    9_
$a Chagas disease (CD) is a neglected disease caused by Trypanosoma cruzi Chagas, 1909. Causative treatment can be achieved with two drugs: benznidazole or Nifurtimox. There are some gaps that hinder progress in eradicating the disease. There is no test that can efficiently assess cure control after treatment. Currently, the decline in anti-T. cruzi antibody titres is assessed with conventional serological tests, which can take years. However, the search for new markers of cure must continue to fill this gap. The present study aimed to evaluate the decline in serological titres using chimeric proteins after treatment with benznidazole in chronic patients diagnosed with CD. It was a prospective cross-sectional cohort study between 2000 and 2004 of T. cruzi-positive participants from the Añatuya region (Argentina) treated with benznidazole. Serum samples from ten patients were collected before treatment (day zero) and after the end of treatment (2, 3, 6, 12, 24 and 36 months). For the detection of anti-T. cruzi antibodies, an indirect ELISA was performed using two chimeric recombinant proteins (IBMP-8.1 and IBMP-8.4) as antigens. The changes in reactivity index within the groups before and after treatment were evaluated using the Friedman test. All participants experienced a decrease in serological titres after treatment with benznidazole, especially IBMP-8.1. However, due to the small number of samples and the short follow-up period, it is premature to conclude that this molecule serves as a criterion for sustained cure. Further studies are needed to validate tests based on these or other biomarkers to demonstrate parasitological cure.
650    _2
$a lidé $7 D006801
650    12
$a Trypanosoma cruzi $7 D014349
650    _2
$a průřezové studie $7 D003430
650    _2
$a prospektivní studie $7 D011446
650    12
$a Chagasova nemoc $x farmakoterapie $7 D014355
650    _2
$a rekombinantní fúzní proteiny $x terapeutické užití $7 D011993
650    12
$a nitroimidazoly $7 D009593
655    _2
$a časopisecké články $7 D016428
700    1_
$a Leony, Leonardo Maia $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000306818332
700    1_
$a de Souza, Wayner Vieira $u Department of Public Health, Aggeu Magalhaes Institute, Oswaldo Cruz Foundation (Fiocruz-PE), Recife, Pernambuco, Brazil $1 https://orcid.org/0000000209399332
700    1_
$a Santos, Emily Ferreira $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000247075494
700    1_
$a Tavares Daltro, Ramona $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000249741972
700    1_
$a Erdens Maron Freitas, Natalia $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000162861883
700    1_
$a Medrado Vasconcelos, Larissa Carvalho $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000348186732
700    1_
$a Lopes Habib, Fernanda $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000182463954
700    1_
$a Silva, Angelo Antonio Oliveira $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $1 https://orcid.org/0000000317236928
700    1_
$a Alejandra Fiorani Celedon, Paola $u Molecular Biology of Trypanosomatids Laboratory, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz-PR), Curitiba, Parana, Brazil $1 https://orcid.org/0000000219687039
700    1_
$a Dias Sampaio, Daniel $u Department Brazil's Family Health Strategy, Municipal Health Department, Tremedal, Bahia, Brazil $1 https://orcid.org/0000000235865157
700    1_
$a Tonin Zanchin, Nilson Ivo $u Structural Biology and Protein Engineering Laboratory, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz-PR), Curitiba, Parana, Brazil $1 https://orcid.org/0000000211530694
700    1_
$a Longhi, Silvia Andrea $u Laboratory of Molecular Biology of Chagas Disease, Institute for Research on Genetic Engineering and Molecular Biology "Dr Hector Torres", National Scientific and Technological Research Council, Buenos Aires, Argentina
700    1_
$a Neves Santos, Fred Luciano $u Advanced Public Health Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz-BA), Salvador, Bahia, Brazil $u Chagas Disease Translational Research Program (Fio-Chagas), Oswaldo Cruz Foundation (Fiocruz-RJ), Rio de Janeiro, Rio de Janeiro, Brazil $1 https://orcid.org/0000000239440818
773    0_
$w MED00011006 $t Folia parasitologica $x 1803-6465 $g Roč. 71 (20240320)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38526232 $y Pubmed
910    __
$a ABA008 $b online $c $y - $z 0
990    __
$a 20250107 $b ABA008
991    __
$a 20250110092628 $b ABA008
999    __
$a kom $b bmc $g 2247202 $s 1236317
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 71 $c - $e 20240320 $i 1803-6465 $m Folia parasitologica $n Folia Parasitol (Praha) $x MED00011006
LZP    __
$a Pubmed-20250107

Najít záznam

Citační ukazatele

Možnosti archivace